Novo Nordisk A/S articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2013/06/03 12:58
2013/06/03 12:58
14d
Novo Nordisk A/S :Share repurchase programme
BAGSVAERD, DENMARK--(Marketwired - Jun 3, 2013) - Company Announcement No 42 2013: This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this...
Read more at Marketwire, Marketwire
2
RELATED
Thomson Reuters Brussels BAGSVAERD HAMILTON Kleinwort Benson
MENTIONED
2013/06/03 12:58
2013/06/03 12:58
Latest videos
2013/05/31 09:28
2013/05/31 09:28
17d
Novo Nordisk A/S: Novo Nordisk files for regulato...
BAGSVAERD, DENMARK--(Marketwired - May 31, 2013) - Novo Nordisk today announced the submission to the European Medicines Agency of the marketing authorisation application for the approval of...
Thomson Reuters BAGSVAERD Novo Nordisk A/S European Medicines Agency
MENTIONED
2013/05/27 13:28
2013/05/27 13:28
21d
Novo Nordisk A/S - Share repurchase programme
BAGSVAERD, DENMARK--(Marketwired - May 27, 2013) - Company Announcement No 40 2013: http://hugin.info/2013/R/1704773/563734.pdf This announcement is distributed by Thomson Reuters on behalf of...
Thomson Reuters BAGSVAERD
MENTIONED
2013/05/24 08:16
2013/05/24 08:16
24d
Most European Stocks Climb Before U.S. Durable-Go...
Most European stocks advanced, after the benchmark Stoxx Europe 600 Index yesterday dropped the most in 10 months, as investors awaited data that may show U.S. durable-goods orders increased in April....
Read more at BusinessWeek, Bloomberg
1
RELATED
Elan Corp. Assicurazioni Generali SpA JPMorgan Chase & Co. Raiffeisen Bank International AG London
MENTIONED
2013/05/21 13:57
2013/05/21 13:57
27d
Novo Nordisk A/S - Share repurchase programme
BAGSVAERD, DENMARK--(Marketwired - May 21, 2013) - On 3 May 2013, Novo Nordisk initiated a share repurchase programme in accordance with the provisions of the European Commission's regulation no...
Read more at Marketwire, Marketwire
1
RELATED
Thomson Reuters Statoil ASA STAVANGER DNB
MENTIONED
2013/05/21 09:28
2013/05/21 09:28
27d
OSLO & COPENHAGEN: Novo A/S acquires Xellia Pharm...
OSLO & COPENHAGEN — Xellia Pharmaceuticals (“Xellia”), a pharmaceutical group focusing on the development, manufacturing and global commercialization of anti-infective therapies, announced today that...
1
RELATED
Xellia Pharmaceuticals Novo Nordisk A/S Copenhagen Oslo Trondheim
MENTIONED
2013/05/20 04:16
2013/05/20 04:16
29d
‘Love Hormone’ Promises Safer Births After Pfizer...
Six years after Pfizer pulled Exubera from the market at a cost of more than $2.8 billion, scientists at Melbourne’s Monash University are revisiting the inhalable technology to deliver a life-saving...
2
RELATED
oxytocin Pfizer John Patton Monash University Melinda Gates Foundation
MENTIONED
2013/05/17 12:57
2013/05/17 12:57
1m
Novo Nordisk reports positive results from first ...
BAGSVAERD, DENMARK--(Marketwired - May 17, 2013) - Novo Nordisk today announced the completion of paradigm™ 2, the first phase 3 trial with a long-acting FIX derivative, N9-GP (glycopegylated...
Thomson Reuters Novo Nordisk A/S BAGSVAERD
MENTIONED
Parts of this website powered by Open Calais, a toolkit for rich semantic metadata extraction.

Huh, what is this?
Interceder is a topic search engine aggregating the latest news on any topic into a single window of information. This page has been automatically generated. To contact Interceder click here.

Privacy Statement
Your privacy is important. Interceder does not collect and keep any personal information about visitors to the site. Interceder may use third-party advertising companies to serve ads. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements on this website, other websites, and other forms of media about goods and services of interest to you.